Livzon Pharmaceutical Group Inc. 的收入按细分市场或地理位置如何划分?
Livzon Pharmaceutical Group Inc. 是否盈利?
Livzon Pharmaceutical Group Inc. 有负债吗?
Livzon Pharmaceutical Group Inc. 的流通股有多少?
关键数据
前收盘价
--
开盘价
--
当日区间
-
52周范围
-
交易量
--
平均成交量
738.2K
每股收益(TTM)
2.64
股息收益率
--
市值
--
什么是 LIVZON PHARMA?
Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 9,067 full-time employees. Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The firm's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The firm's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The firm mainly operates its businesses in the domestic and overseas markets.